Chairman Zhao Yan visited Shanghai R&D Center and pointed out that innovation was the fate of enterprises

2020.12.28

Zhao Yan, Chairman of Bloomage Biotech, came to Shanghai R&D Center, inspected the daily work and progress of each project, and had a discussion with all employees on June 23. 

会议室里的人们

描述已自动生成

When listening to the work report of Shanghai R&D Center, Chairman Zhao Yan emphasized that Bloomage Biotech, as a biotech company listed on the science and technology innovation board, was focused on the research and application development of bioactive substances necessary for human life and health. The original intention of establishing Shanghai R&D Center was to let the company continue to maintain the basis of research advantages on bioactive substances, and further expand and strengthen the company's ability in the development and innovation of terminal products.

Chairman Zhao Yan also said that 2020 was an unusual year. Under the impact of the epidemic, Bloomage Biotech always pays attention to the long-term development and happiness of employees. The company must rely on science and Technology power + Product power + Brand power to obtain immunity against risks, so research and innovation is more important. For 20 years, Bloomage Biotech has focused on a substance-hyaluronic acid research, and has achieved the world's largest scale of industrialization. With the development of C-terminal business, the company has a good momentum of development, and many terminal products have been recognized and affirmed by consumers. It is hoped that all employees of Shanghai R&D Center would adhere to innovation as their mission, be brave in innovation, be good at innovation, and make good products that Chinese people like and proud of.

After the meeting, Chairman Zhao Yan also listened to the competition report of the three individual research and development studios in Shanghai R & D Center.